In recurrent strokes, biomarker measurements were similar in the sample collected in the first and in the second episode (IL-6, 9.1 ± 6.9 pg/mL vs. 9.4 ± 7.5 pg/mL, p = 0.330; TNFα, 15.8 ± 5.8 pg/mL vs. 16.0 ± 7.0 pg/mL, p = 0.168; sTWEAK, 8,763.4 ± 5,167.3 pg/mL vs. 8,767.3 ± 4,126.0 pg/mL, p = 0.992). The gene discussed is IL6; the disease is stroke disorder.